You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tolterodine Tartrate

Showing 1 - 25 of 228
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,

Recruiting
  • Urinary Incontinence, Urge
  • +5 more
  • Tolterodine Tartrate ER
  • +2 more
  • Palo Alto, California
  • +1 more
Dec 7, 2022

Overactive Bladder, Obstructive Sleep Apnea, Overactive Bladder Syndrome Trial in Van (Tolterodine Tartrate 4 MG, Continuous

Completed
  • Overactive Bladder
  • +2 more
  • Tolterodine Tartrate 4 MG
  • Continuous positive airway pressure therapy (CPAP)
  • Van, Turkey
    Yuzuncu Yıl University
Feb 10, 2022

Urinary Bladder, Overactive Trial in Singapore (tolterodine tartrate)

Completed
  • Urinary Bladder, Overactive
  • tolterodine tartrate
  • Singapore, Singapore
    Pfizer Investigational Site
Jan 26, 2021

.(Post Marketing Commitment Plan)

Completed
Has Results
  • Overactive Bladder
  • Tolterodine tartrate
  • (no location specified)
Jan 26, 2021

Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

Recruiting
  • Sjogren's Syndrome
  • Overactive Bladder Syndrome
  • Taichung, Taiwan
    China Medical University Hospital
Aug 8, 2021

Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)

Not yet recruiting
  • Female Patients With Overactive Bladder Syndrome
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023

Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence Trial in Cairo

Completed
  • Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence
  • Low dose tadalafil 5 mg
  • +2 more
  • Cairo, Egypt
    Samer Morsy
Aug 11, 2022

Urinary Incontinence Trial (tolterodine SR, overactive bladder)

Completed
  • Urinary Incontinence
  • tolterodine SR, overactive bladder
  • (no location specified)
Jan 26, 2021

Urinary Incontinence Trial in China (tolterodine extended release capsule)

Completed
  • Urinary Incontinence
  • tolterodine extended release capsule
  • Beijing, Beijing, China
  • +6 more
Jan 26, 2021

Urge Incontinence, Urinary Incontinence, Urge Trial in San Francisco (Mirabegron, Tolterodine Tartrate)

Completed
Has Results
  • Urge Incontinence
  • Urinary Incontinence, Urge
  • San Francisco, California
    University of California, San Francisco
Mar 28, 2019

Memory, Cognition Trial in United States (Tolterodine ER, Oxybutynin ER)

Completed
  • Memory
  • Cognition
  • Tolterodine ER
  • Oxybutynin ER
  • Tucson, Arizona
  • +8 more
Jan 26, 2021

Urinary Incontinence Trial in United Kingdom (Tolterodine ER, Placebo)

Completed
  • Urinary Incontinence
  • Tolterodine ER
  • Placebo
  • Blackburn, Lancashire, United Kingdom
  • +10 more
Jan 26, 2021

Urinary Incontinence Trial in United States (Tolterodine ER 4mg QD)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4mg QD
  • Chandler, Arizona
  • +57 more
Jan 26, 2021

Urinary Bladder, Overactive Trial in United States (tolterodine extended release)

Completed
  • Urinary Bladder, Overactive
  • tolterodine extended release
  • Birmingham, Alabama
  • +95 more
Jan 26, 2021

Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, OAB Patient Behavioral Training Material)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4 mg QD
  • OAB Patient Behavioral Training Material
  • Phoenix, Arizona
  • +50 more
Jan 26, 2021

Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)

Completed
Has Results
  • Urinary Incontinence
  • Urgency Urinary
  • Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
  • Boston, Massachusetts
    Brigham & Women's Hospital
Oct 21, 2022

Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4 mg QD
  • Tamsulosin 0.4 mg QD
  • Birmingham, Alabama
  • +94 more
Jan 26, 2021

Overactive Bladder Trial in Zurich (Tolterodine, Filling cystometry, Intravesical neurostimulation)

Completed
  • Overactive Bladder
  • Zurich, Switzerland
    Pfizer Investigational Site
Jan 26, 2021

Overactive Bladder Trial in United States (Vibegron, s, Tolterodine Tartrate ER)

Completed
Has Results
  • Overactive Bladder
  • Mobile, Alabama
  • +106 more
Feb 19, 2021

Overactive Bladder Trial in San Francisco (Tolterodine ER, Placebo)

Terminated
Has Results
  • Overactive Bladder
  • Tolterodine ER
  • Placebo
  • San Francisco, California
  • +1 more
Jan 26, 2021

Overactive Bladder (OAB) Trial in Worldwide (Detrol LA)

Completed
  • Overactive Bladder (OAB)
  • Detrol LA
  • Anaheim, California
  • +80 more
Jan 26, 2021

Overactive Bladder Trial in Irwon-dong, Gyeonggi-do, Seoul (Tolterodine, Tolterodine 6)

Completed
  • Overactive Bladder
  • Irwon-dong, Seoul, Korea, Republic of
  • +3 more
Nov 28, 2019

Overactive Bladder Trial in Worldwide (vibegron, Vibegron , Tolterodine Tartrate ER)

Completed
Has Results
  • Overactive Bladder
  • Birmingham, Alabama
  • +214 more
Feb 11, 2021

Overactive Bladder Trial (tolterodine tartrate, Comparator: Placebo to tolterodine tartrate)

Completed
Has Results
  • Overactive Bladder
  • tolterodine tartrate
  • Comparator: Placebo to tolterodine tartrate
  • (no location specified)
Jan 24, 2018

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023